Literature DB >> 23589150

The role of endothelial insulin signaling in the regulation of glucose metabolism.

Tetsuya Kubota1, Naoto Kubota, Takashi Kadowaki.   

Abstract

The skeletal muscle is one of the major target organs of insulin and plays an essential role in insulin-induced glucose uptake. Some evidence indicates that insulin delivery to skeletal muscle interstitium through the endothelial cells is the rate-limiting step in insulin-stimulated glucose uptake. Researchers have also found that this process is impaired by insulin resistance in type 2 diabetes and obesity. A recent study of ours demonstrated that insulin signaling in the endothelial cells plays a pivotal role in the regulation of glucose uptake by the skeletal muscle. Specifically, impaired insulin signaling in the endothelial cells, with reduction of insulin-induced eNOS phosphorylation, causes attenuation of the insulin-induced capillary recruitment and insulin delivery, which, in turn reduces glucose uptake by the skeletal muscle in high-fat diet-fed mice. Moreover, restoration of the insulin-induced eNOS phosphorylation in the endothelial cells completely reverses the reduction in the capillary recruitment and insulin delivery, and as a result, significantly restores glucose uptake by the skeletal muscle. In the present review, we describe the recent progress in research on the physiological and pathophysiological roles of endothelial insulin signaling in the regulation of insulin-induced glucose uptake by the skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23589150     DOI: 10.1007/s11154-013-9242-z

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  88 in total

1.  Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice.

Authors:  William L Holland; Benjamin T Bikman; Li-Ping Wang; Guan Yuguang; Katherine M Sargent; Sarada Bulchand; Trina A Knotts; Guanghou Shui; Deborah J Clegg; Markus R Wenk; Michael J Pagliassotti; Philipp E Scherer; Scott A Summers
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

Review 2.  Critical nodes in signalling pathways: insights into insulin action.

Authors:  Cullen M Taniguchi; Brice Emanuelli; C Ronald Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

Review 3.  Diabetes in Asia: epidemiology, risk factors, and pathophysiology.

Authors:  Juliana C N Chan; Vasanti Malik; Weiping Jia; Takashi Kadowaki; Chittaranjan S Yajnik; Kun-Ho Yoon; Frank B Hu
Journal:  JAMA       Date:  2009-05-27       Impact factor: 56.272

4.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion.

Authors:  K Wei; A R Jayaweera; S Firoozan; A Linka; D M Skyba; S Kaul
Journal:  Circulation       Date:  1998-02-10       Impact factor: 29.690

5.  Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group.

Authors:  M Lièvre; S Morand; B Besse; J N Fiessinger; J P Boissel
Journal:  Circulation       Date:  2000-07-25       Impact factor: 29.690

Review 6.  Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome?

Authors:  Erik H Serné; Renate T de Jongh; Etto C Eringa; Richard G Ijzerman; Michiel P de Boer; Coen D A Stehouwer
Journal:  Essays Biochem       Date:  2006       Impact factor: 8.000

7.  Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study.

Authors:  B Balkau; G Hu; Q Qiao; J Tuomilehto; K Borch-Johnsen; K Pyörälä
Journal:  Diabetologia       Date:  2004-12-15       Impact factor: 10.122

8.  Enhancement by beraprost sodium, a stable analogue of prostacyclin, in thrombomodulin expression on membrane surface of cultured vascular endothelial cells via increase in cyclic AMP level.

Authors:  M Kainoh; I Maruyama; S Nishio; T Nakadate
Journal:  Biochem Pharmacol       Date:  1991-04-15       Impact factor: 5.858

9.  In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects.

Authors:  R Prager; P Wallace; J M Olefsky
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

Review 10.  Endothelial dysfunction in insulin resistance and type 2 diabetes.

Authors:  P-A Jansson
Journal:  J Intern Med       Date:  2007-08       Impact factor: 8.989

View more
  16 in total

Review 1.  Map4k4 Signaling Nodes in Metabolic and Cardiovascular Diseases.

Authors:  Joseph V Virbasius; Michael P Czech
Journal:  Trends Endocrinol Metab       Date:  2016-05-06       Impact factor: 12.015

2.  Map4k4 impairs energy metabolism in endothelial cells and promotes insulin resistance in obesity.

Authors:  Rachel J Roth Flach; Marina T DiStefano; Laura V Danai; Ozlem Senol-Cosar; Joseph C Yawe; Mark Kelly; Lorena Garcia Menendez; Michael P Czech
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-06-13       Impact factor: 4.310

Review 3.  Emerging Roles of Vascular Endothelium in Metabolic Homeostasis.

Authors:  Xinchun Pi; Liang Xie; Cam Patterson
Journal:  Circ Res       Date:  2018-08-03       Impact factor: 17.367

4.  Evidence stacks up that endothelial insulin resistance is a culprit in atherosclerosis.

Authors:  Jenny E Kanter; Karin E Bornfeldt
Journal:  Circ Res       Date:  2013-08-02       Impact factor: 17.367

5.  Insulin access to skeletal muscle is impaired during the early stages of diet-induced obesity.

Authors:  Josiane L Broussard; Ana V B Castro; Malini Iyer; Rebecca L Paszkiewicz; Isaac Asare Bediako; Lidia S Szczepaniak; Edward W Szczepaniak; Richard N Bergman; Cathryn M Kolka
Journal:  Obesity (Silver Spring)       Date:  2016-09       Impact factor: 5.002

Review 6.  Role of habitual physical activity in modulating vascular actions of insulin.

Authors:  Jaume Padilla; T Dylan Olver; John P Thyfault; Paul J Fadel
Journal:  Exp Physiol       Date:  2015-07-01       Impact factor: 2.969

7.  Endothelial TFEB (Transcription Factor EB) Improves Glucose Tolerance via Upregulation of IRS (Insulin Receptor Substrate) 1 and IRS2.

Authors:  Jinjian Sun; Haocheng Lu; Wenying Liang; Guizhen Zhao; Lu Ren; Die Hu; Ziyi Chang; Yuhao Liu; Minerva T Garcia-Barrio; Jifeng Zhang; Y Eugene Chen; Yanbo Fan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-10       Impact factor: 8.311

8.  Differences in muscle transcriptome among pigs phenotypically extreme for fatty acid composition.

Authors:  Anna Puig-Oliveras; Yuliaxis Ramayo-Caldas; Jordi Corominas; Jordi Estellé; Dafne Pérez-Montarelo; Nicholas J Hudson; Joaquim Casellas; Josep M Folch; Maria Ballester
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

9.  CD226 reduces endothelial cell glucose uptake under hyperglycemic conditions with inflammation in type 2 diabetes mellitus.

Authors:  Yuan Zhang; Tian Liu; Yu Chen; Zilong Dong; Jinxue Zhang; Yizheng Sun; Boquan Jin; Feng Gao; Shuzhong Guo; Ran Zhuang
Journal:  Oncotarget       Date:  2016-03-15

Review 10.  Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance.

Authors:  Manna Li; Ming Qian; Jian Xu
Journal:  Front Cardiovasc Med       Date:  2017-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.